BOC 241220 10.00P (BOC241220P10000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BOC241220P10000

Watchlist

0.05
0.000.00%

15min DelayClose Nov 29 13:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

TD Cowen Sticks to Their Buy Rating for Boston Omaha (BOC)
TipRanksNov 20 07:26 ET · Ratings
Boston Omaha Corporation's (NYSE:BOC) P/S Is On The Mark
Simply Wall StNov 19 05:01 ET
Mixed Performance in Boston Omaha's Insurance and Broadband Segments Leads to Hold Rating
TipRanksNov 15 05:29 ET · Ratings
Boston Omaha Reports Q3 2024 Financial Results
TipRanksNov 12 17:08 ET
Boston Omaha | 8-K: BOSTON OMAHA CORPORATION ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS
SECNov 12 16:30 ET
Boston Omaha 3Q Rev $27.7M >BOC
Dow JonesNov 12 16:27 ET

Comments

70981574

Nov 27 07:39

$T Stamp (IDAI.US)$ Premarket ticks- by Stock_Driff
$Fangdd Network (DUO.US)$ $Tenaya Therapeutics (TNYA.US)$ $Boston Omaha (BOC.US)$ $nCino (NCNO.US)$ $TuHURA Biosciences (HURA.US)$ $Defiance Daily Target 2X Long MSTR ETF (MSTX.US)$ $Ocean Power Technologies (OPTT.US)$ $Ambarella (AMBA.US)$ $Kaixin Holdings (KXIN.US)$ $T Stamp (IDAI.US)$ $Quantum (QMCO.US)$ $Cyclerion Therapeutics (CYCN.US)$ $Infobird Software (IFBD.US)$ $HWH International (HWH.US)$

Stock_Drift

Nov 27 04:43

Premarket Ticks. 5:42am 11/27

$Fangdd Network (DUO.US)$ $Tenaya Therapeutics (TNYA.US)$ $Boston Omaha (BOC.US)$ $nCino (NCNO.US)$ $TuHURA Biosciences (HURA.US)$ $Defiance Daily Target 2X Long MSTR ETF (MSTX.US)$ $Ocean Power Technologies (OPTT.US)$ $Ambarella (AMBA.US)$ $Kaixin Holdings (KXIN.US)$ $T Stamp (IDAI.US)$ $Quantum (QMCO.US)$ $Cyclerion Therapeutics (CYCN.US)$ $Infobird Software (IFBD.US)$ $HWH International (HWH.US)$
📊⚡️📊

MARKET-TEST-DUMMY

Jun 19 19:25

Come on volume

$Boston Omaha (BOC.US)$ where ya at

95 Pct Confidence

Oct 27, 2023 07:08

Time to buy some

$Boston Omaha (BOC.US)$

Moomoo Breakfast US

Jul 6, 2022 07:39

Columns Today's pre-market stock movers: DASH, UBER, RKLB, BIIB and more

Gainers:
• $Resolute Forest Products (RFP.US)$ +65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right)
• $Applied Molecular (AMTI.US)$ +2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101)
• $Primoris Services (PRIM.US)$ +2.1% (awarded a $170 mln project by Texas DOT)
• $Biogen (BIIB.US)$ +2.1% (Bi...